FNDC3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.149600E-01
Normal-vs-Stage2
5.703000E-01
Normal-vs-Stage3
5.640800E-01
Normal-vs-Stage4
4.904800E-01
Stage1-vs-Stage2
2.697400E-01
Stage1-vs-Stage3
5.042800E-01
Stage1-vs-Stage4
1.985170E-01
Stage2-vs-Stage3
1.592590E-01
Stage2-vs-Stage4
5.384600E-01
Stage3-vs-Stage4
1.768790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.122200E-01
Normal-vs-AfricanAmerican
6.735000E-01
Normal-vs-Asian
8.050800E-01
Caucasian-vs-AfricanAmerican
7.663200E-01
Caucasian-vs-Asian
8.296600E-01
AfricanAmerican-vs-Asian
7.012200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.689800E-01
Normal-vs-Female
6.915200E-01
Male-vs-Female
6.609600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.529600E-01
Normal-vs-Age(41-60Yrs)
2.964400E-01
Normal-vs-Age(61-80Yrs)
8.713000E-01
Normal-vs-Age(81-100Yrs)
8.111600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.568760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.828000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.307600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.181120E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.762050E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.082200E-01
Normal-vs-Daily Drinker
7.426800E-01
Normal-vs-Weekly Drinker
7.452800E-01
Normal-vs-Occasional Drinker
4.922200E-01
Normal-vs-Social Drinker
6.368000E-01
Non Drinker-vs-Daily Drinker
3.645600E-01
Non Drinker-vs-Weekly Drinker
7.190200E-01
Non Drinker-vs-Occasional Drinker
1.458040E-01
Non Drinker-vs-Social Drinker
3.923000E-01
Daily Drinker-vs-Weekly Drinker
2.122200E-01
Daily Drinker-vs-Occasional Drinker
5.676500E-02
Daily Drinker-vs-Social Drinker
1.144820E-01
Weekly Drinker-vs-Occasional Drinker
2.263800E-01
Weekly Drinker-vs-Social Drinker
6.411600E-01
Occasional Drinker-vs-Social Drinker
4.472400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.033600E-01
Normal-vs-Grade 2
5.928000E-02
Normal-vs-Grade 3
1.363630E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.775750E-03
Grade 1-vs-Grade 3
9.446400E-04
Grade 1-vs-Grade 4
4.033600E-01
Grade 2-vs-Grade 3
1.485760E-01
Grade 2-vs-Grade 4
5.928000E-02
Grade 3-vs-Grade 4
1.363630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.303200E-01
Normal-vs-NonDiabetic
7.254400E-01
Diabetic-vs-NonDiabetic
6.596600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.095400E-01
Normal-vs-NoPancreatitis
7.169200E-01
Pancreatitis-vs-NoPancreatitis
7.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.039800E-01
Normal-vs-N1
5.429800E-01
N0-vs-N1
2.144200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.780000E-01
Normal-vs-TP53-NonMutant
7.694200E-01
TP53-Mutant-vs-TP53-NonMutant
5.225900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
